Acadia could rake in $2 billion in revenue from Nuplazid Outlook Strategies Acadia’s Parkinson’s drug Nuplazid clears key hurdle
The correlation between stocks and oil is at a multi-year high Strategies Behind a roller coaster first quarter
Yields of over 10% are common in mortgage REITs Outlook Strategies The frantic search for dividend yield
We're happy with our low exposure to the stock market Outlook Strategies Navigating the choppy market waters
Amazon and Apple disappointed investors on earnings Outlook Strategies Why our 2016 outlook still remains bearish
Good news: Oil prices show promising signs of stabilizing Outlook Strategies Oil prices in search of a bottom
A closer look at the proposed takeover of ADT yields insights Outlook Strategies Unlocking home security giant ADT’s value
